Adalimumab-induced pyoderma gangrenosum in a patient with hidradenitis suppurativa: A paradoxical reaction

Indian J Dermatol Venereol Leprol. 2019 Jul-Aug;85(4):422-425. doi: 10.4103/ijdvl.IJDVL_277_18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / adverse effects*
  • Anti-Inflammatory Agents / adverse effects*
  • Hidradenitis Suppurativa / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Pyoderma Gangrenosum / chemically induced*

Substances

  • Anti-Inflammatory Agents
  • Adalimumab